We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$23.6B
AUM Growth
+$1.71B
Cap. Flow
-$406M
Cap. Flow %
-1.72%
Top 10 Hldgs %
52.37%
Holding
196
New
43
Increased
37
Reduced
38
Closed
21

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$502M
2
UNH icon
UnitedHealth
UNH
+$254M
3
ABNB icon
Airbnb
ABNB
+$243M
4
AON icon
Aon
AON
+$196M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$152M

Top Sells

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$311M
2
TMO icon
Thermo Fisher Scientific
TMO
+$228M
3
BX icon
Blackstone
BX
+$222M
4
TRU icon
TransUnion
TRU
+$203M
5
SPLK
Splunk Inc
SPLK
+$202M

Sector Composition

Rank Sector Weight
1 Healthcare 26.88%
2 Technology 10.2%
3 Financials 8.76%
4 Energy 8.1%
5 Industrials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
126
HCA Healthcare
HCA
$92.9B
$334K ﹤0.01%
1,000
-19,900
-95% -$6.08M
AXSM icon
127
Axsome Therapeutics
AXSM
$10.9B
$319K ﹤0.01%
4,000
– –
ALNY icon
128
Alnylam Pharmaceuticals
ALNY
$31.6B
$299K ﹤0.01%
2,000
– –
ACLX
129
DELISTED
Arcellx
ACLX
$278K ﹤0.01%
4,000
– –
CHE icon
130
Chemed
CHE
$7.07B
$257K ﹤0.01%
400
– –
EHC icon
131
Encompass Health
EHC
$11.9B
$248K ﹤0.01%
3,000
– –
SWTX
132
DELISTED
SpringWorks Therapeutics
SWTX
$246K ﹤0.01%
+5,000
New +$231K
GKOS icon
133
Glaukos
GKOS
$10.9B
$245K ﹤0.01%
2,600
– –
BTSG icon
134
BrightSpring Health Services
BTSG
$11.6B
$239K ﹤0.01%
+22,000
New +$220K
SNDX icon
135
Syndax Pharmaceuticals
SNDX
$1.75B
$238K ﹤0.01%
10,000
– –
CRNX icon
136
Crinetics Pharmaceuticals
CRNX
$8.99B
$234K ﹤0.01%
5,000
-117,904
-96% -$4.61M
ALPN
137
DELISTED
Alpine Immune Sciences Inc
ALPN
$234K ﹤0.01%
+5,900
New +$174K
CCCC icon
138
C4 Therapeutics
CCCC
$492M
$229K ﹤0.01%
+28,000
New +$217K
HQY icon
139
HealthEquity
HQY
$8.81B
$229K ﹤0.01%
+2,800
New +$219K
MMSI icon
140
Merit Medical Systems
MMSI
$5.42B
$227K ﹤0.01%
+3,000
New +$232K
ACHC icon
141
Acadia Healthcare
ACHC
$2.59B
$222K ﹤0.01%
2,800
– –
IDYA icon
142
IDEAYA Biosciences
IDYA
$3.83B
$219K ﹤0.01%
+5,000
New +$215K
SBRA icon
143
Sabra Healthcare REIT
SBRA
$5.21B
$207K ﹤0.01%
14,000
– –
RCM
144
DELISTED
R1 RCM Inc. Common Stock
RCM
$206K ﹤0.01%
16,000
– –
FOLD
145
DELISTED
Amicus Therapeutics
FOLD
$188K ﹤0.01%
16,000
– –
GRFS
146
Grifois
GRFS
$5.44B
$187K ﹤0.01%
+28,000
New +$219K
ARDX icon
147
Ardelyx
ARDX
$1B
$168K ﹤0.01%
+23,000
New +$197K
OSCR icon
148
Oscar Health
OSCR
$9.89B
$164K ﹤0.01%
+11,000
New +$151K
SCRMW
149
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$157K ﹤0.01%
333,330
– –
BYND icon
150
Beyond Meat
BYND
$254M
$157K ﹤0.01%
+633
New +$146K
4 5
6
7 8

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2024 Portfolio in Review

As of Q1 2024, Thomas Steyer held 196 positions worth $23.6B, up 7.8% from $21.9B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Thomas Steyer's Q1 2024 filing shows 43 new, 37 increased, 38 reduced and 21 closed positions. Its largest new stake was Airbnb: 1,608,220 shares worth $265M. The largest sale was Charter Communications, an estimated $311M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Thomas Steyer's largest Q1 2024 buy was Airbnb: 1,608,220 shares worth $265M.
  • Thomas Steyer added most to Hess in Q1 2024, an estimated $502M increase.
  • Thomas Steyer's biggest Q1 2024 reduction was Thermo Fisher Scientific, cutting an estimated $228M.
  • Thomas Steyer fully exited Charter Communications in Q1 2024, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 52% of its $23.6B portfolio in Q1 2024.
  • Thomas Steyer opened 43 new positions and closed 21 in Q1 2024.
  • Thomas Steyer's portfolio value rose 7.8% quarter-over-quarter to $23.6B.

Based on Farallon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.